News

Sterling Pharma Solutions acquires API facility in US

1 October 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Sterling Pharma Solutions, regarding the acquisition of Alcami’s Germantown, Wisconsin facility in the US. Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its…Read more


IONTAS and FairJourney Biologics Discover SARS-CoV2 Neutralising Antibodies with Picomolar Potency

28 September 2020 Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing Monoclonal antibodies have the potential to both treat infected patients and provide protection to the “at risk” population during the pandemic Viral neutralisation data independently verified by the National Institute for Biological Standards and Control (NIBSC) Project…Read more


GHO Capital acquires X-Chem, a leading drug discovery service provider

Matt Clark named new Chief Executive Officer US-based X-Chem is the leading provider of small molecule discovery services to global biopharma using DNA-Encoded Library technology GHO to invest further in best-in-class technology and service proposition 3 June 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in…Read more


FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services

FairJourney’s combination with Iontas creates a leading global antibody discovery CRO with an international footprint FairJourney’s unique antibody discovery libraries and service portfolio to be complemented by Iontas’ proprietary mammalian display technology Group to have an unparalleled service and technology offering across antibody discovery, engineering, characterisation, and manufacturing services 13 May 2020 London, UK – Global…Read more


Sterling Pharma Solutions commences the production of potential COVID-19 treatment

11 May 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Sterling Pharma Solutions, regarding the commencement of the production of potential COVID-19 treatment. Global Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ),…Read more


Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment

16 April 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, FairJourney Biologics, regarding the partnership with Iontas in search for SARS-CoV-2 treatment. FairJourney Biologics (Porto, Portugal) and Iontas (Cambridge, UK) today announce a partnership to expedite the identification of…Read more


Envision Pharma announces acquisition of London-based behavioural science-led communications group 90TEN

08 April 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Envision Pharma Group, regarding the acquisition of 90TEN. Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group – a global provider of evidence-based communication services and…Read more


GHO Capital invests in FairJourney Biologics, a global leader in monoclonal antibody discovery services for biopharma

30 January 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, announces its investment to partner with the founding management team in FairJourney Biologics (‘FairJourney’), a leader in providing antibody discovery services to global biopharma. Established in 2012 in Porto, Portugal, FairJourney provides outsourced antibody discovery,…Read more


GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma.

9 January 2020 London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, has acquired Ardena, a specialist contract development and manufacturing organisation (CDMO) focused on early phase drug development, from Mentha Capital and existing management. Ardena is a multi-service CDMO, assisting small-to-mid sized biopharma with services spanning…Read more


GHO Capital raises €975m in largest ever European healthcare fund

€975m fundraise marks the largest ever specialist private equity fund dedicated to investing in European healthcare Fund II will invest in high growth healthcare subsectors, including outsourced services, pharma and medtech Oversubscribed fund is 50% larger than GHO’s 2015 maiden fund, demonstrating strong support from existing and new investors alike 20 November 2019 London, UK –…Read more